Kristina Lindenau
Humboldt University of Berlin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kristina Lindenau.
Nephron | 1986
Kristina Lindenau; Kokot F; Peter T. Fröhling
In the present study the influence of a mixture of keto analogues/amino acids (KA) on PTH levels in 18 RDT patients was examined. Ten of them were treated with KA over a period of 3 months, while the other 8 patients served as control group. The KA-treated patients showed a significant fall in PTH and plasma phosphate levels, while no changes of plasma 25-OH-D or plasma calcitonin were observed. Consequently, KA administration may also be beneficial with respect to control of secondary hyperparathyroidism.
Nephron | 1990
Kristina Lindenau; Klaus Abendroth; Kokot F; K. Vetter; Christoph Rehse; Peter T. Fröhling
The therapeutical effect of keto acids on bone histology was investigated in a prospective randomized controlled study of 40 patients. A marked improvement in osteofibrotic as well as in osteomalacic changes was found in bone biopsies after 12 months of treatment with keto acids.
Nephron | 1986
Peter T. Fröhling; Maria Birnbaum; Horst Halle; Kristina Lindenau
A case is reported of a successful pregnancy of a woman with advanced renal failure treated nutritionally. The importance of an intensive interdisciplinary medical co-working is stressed, and the individual adaptation of the dietary treatment to the special nutritional requirements in pregnancy is discussed.
Contributions To Nephrology | 1988
Peter T. Fröhling; R. Schmicker; Kristina Lindenau; K. Vetter; Kokot F
KA administration given in addition to a low-protein diet leads to a reduction of PTH secretion followed by diminishing of osteofibrosis. Osteomalacia will also be reduced by a better control of the calcium-phosphate metabolism, an increase of 1,25-(OH)2-D levels, and a lower burden of aluminum. Therapeutic levels of 25-OH-D and calcitonin (caused by simultaneous administration of vitamin D) are probably necessary to achieve this effect. KA are not only the optimum form of substitution in the nutritional treatment of chronic renal failure, but they seem to be very effective in the treatment of renal osteodystrophy.
Contributions To Nephrology | 1990
Peter T. Fröhling; Ingrid Kaschube; K. Vetter; Elisabeth Knäbich; Kristina Lindenau; R. Schmicker
Contributions To Nephrology | 1988
Peter T. Fröhling; Kokot F; K. Vetter; Ingrid Kaschube; Kristina Lindenau; J. Pfitzner; R. Schmicker
Contributions To Nephrology | 1988
Kristina Lindenau; Kokot F; K. Vetter; Peter T. Fröhling; R. Schmicker; U. Futh; I. Grossmann
Contributions To Nephrology | 1986
P. T. Froehling; K. Kokot; K. Vetter; Ingrid Kaschube; Kristina Lindenau
Contributions To Nephrology | 1990
K. Vetter; Ingrid Kaschube; C. Metzner; Kristina Lindenau; Peter T. Fröhling
Contributions To Nephrology | 1984
Peter T. Fröhling; Kokot F; K. Vetter; W. D. Hohmann; G. Werner; I. Grossmann; R. Schmicker; Kristina Lindenau